Synopsis
Synopsis
0
USDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1 Alpha,24-dihydroxycholecalciferol
2. 1 Alpha,24-dihydroxyvitamin D3
3. 1 Alpha,24-dihydroxyvitamin D3, (1alpha,3beta,5z,7e,24r)-isomer
4. 1 Alpha,24-dihydroxyvitamin D3, (1alpha,3beta,5z,7e,24s)-isomer
5. 1,24-dihydroxycholecalciferol
6. 1,24-dihydroxyvitamin D3
7. Curatoderm
8. Pri-2191
1. 57333-96-7
2. Bonalfa
3. Curatoderm
4. Tacalcitolum
5. Tv-02h
6. Tv-02
7. Unii-c2w72oj5zu
8. Pri 2191
9. 1-alpha,24(r)-dihydroxyvitamin D3
10. (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-1-[(2r,5r)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
11. Tv 02
12. Pri-2191
13. C2w72oj5zu
14. 1.alpha.,24-dihydroxyvitamin D3
15. 1alpha,24(r)-dihydroxyvitamin D3
16. Tacalcitol (inn)
17. Tacalcitol [inn]
18. 1,24-dihydroxyvitamin D3
19. (24r)-1alpha,24-dihydroxyvitamin D3 / (24r)-1alpha,24-dihydroxycholecalciferol
20. (5z,7e)-(1s,3r,24r)-9,10-seco-5,7,10(19)-cholestatriene-1,3,24-triol
21. (1r,3s,z)-5-((e)-2-((1r,3as,7ar)-1-((2r,5r)-5-hydroxy-6-methylheptan-2-yl)-7a-methylhexahydro-1h-inden-4(2h)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
22. Bonalfa (tn)
23. Tacalcitolum [inn-latin]
24. 1,24(r)-dihydroxyvitamin D3
25. Chebi:32176
26. Tacalcitol [inn:ban:jan]
27. Vellutan
28. Apsor
29. Ccris 4211
30. Tv02
31. Tacalcitol [mi]
32. 1alpha,24(oh)2d3
33. Schembl3945
34. Tacalcitol [mart.]
35. Tacalcitol [who-dd]
36. Tv-02hs
37. 1a,24-dihydroxycholecalciferol
38. Gtpl2780
39. Chembl2105611
40. Tacalcitol, >=99% (hplc)
41. Dtxsid90905111
42. Ex-a4429
43. Zinc4474668
44. Bdbm50441892
45. Lmst03020256
46. Akos024458008
47. Cs-0391
48. Db13689
49. (1-alpha,3-beta,5z,7e,24r)-9,10-secocholesta-5,7,10(19)-triene-1,3,24-triol
50. As-77643
51. Hy-32337
52. (1alpha,24r)-1,24-dihydroxyvitamin D3
53. 1.alpha.,24-dihydroxycholecalciferol
54. D08554
55. 333t967
56. Q155682
57. 1,24(r)-dihydroxyvitamin D3;1.alpha.,24r-dihydroxyvitamin D3
58. (1s,3r,5z,7e,24r)-9,10-secocholesta-5,7,10-triene-1,3,24-triol
59. (+)-(5z,7e,24r)-9,10-secocholesta-5,7,10(19)-triene-1alpha,3beta,24-triol
60. (1?,3?,5z,7e,24r)-9,10-secocholesta-5,7,10(19)-triene-1,3,24-triol
61. 1s,3r,5z,7e,24r)-9,10-secocholesta-5,7,10-triene-1,3,24-triol
62. 9,10-secocholesta-5,7,10(19)-triene-1,3,24-triol, (1-alpha,3-beta,5z,7e,24r)-
63. (+)-(5z,7e,24r)-9,10-secocholesta-5,7,10(19)-triene-1.alpha.,3.beta.,24-triol
Molecular Weight | 416.6 g/mol |
---|---|
Molecular Formula | C27H44O3 |
XLogP3 | 5.3 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 6 |
Exact Mass | 416.32904526 g/mol |
Monoisotopic Mass | 416.32904526 g/mol |
Topological Polar Surface Area | 60.7 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 676 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Dermatologic Agents
Drugs used to treat or prevent skin disorders or for the routine care of skin. (See all compounds classified as Dermatologic Agents.)
D - Dermatologicals
D05 - Antipsoriatics
D05A - Antipsoriatics for topical use
D05AX - Other antipsoriatics for topical use
D05AX04 - Tacalcitol
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tacalcitol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tacalcitol, including repackagers and relabelers. The FDA regulates Tacalcitol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tacalcitol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tacalcitol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tacalcitol supplier is an individual or a company that provides Tacalcitol active pharmaceutical ingredient (API) or Tacalcitol finished formulations upon request. The Tacalcitol suppliers may include Tacalcitol API manufacturers, exporters, distributors and traders.
click here to find a list of Tacalcitol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tacalcitol Drug Master File in Japan (Tacalcitol JDMF) empowers Tacalcitol API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tacalcitol JDMF during the approval evaluation for pharmaceutical products. At the time of Tacalcitol JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tacalcitol suppliers with JDMF on PharmaCompass.
A Tacalcitol CEP of the European Pharmacopoeia monograph is often referred to as a Tacalcitol Certificate of Suitability (COS). The purpose of a Tacalcitol CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tacalcitol EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tacalcitol to their clients by showing that a Tacalcitol CEP has been issued for it. The manufacturer submits a Tacalcitol CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tacalcitol CEP holder for the record. Additionally, the data presented in the Tacalcitol CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tacalcitol DMF.
A Tacalcitol CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tacalcitol CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tacalcitol suppliers with CEP (COS) on PharmaCompass.
Tacalcitol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tacalcitol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tacalcitol GMP manufacturer or Tacalcitol GMP API supplier for your needs.
A Tacalcitol CoA (Certificate of Analysis) is a formal document that attests to Tacalcitol's compliance with Tacalcitol specifications and serves as a tool for batch-level quality control.
Tacalcitol CoA mostly includes findings from lab analyses of a specific batch. For each Tacalcitol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tacalcitol may be tested according to a variety of international standards, such as European Pharmacopoeia (Tacalcitol EP), Tacalcitol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tacalcitol USP).
LOOKING FOR A SUPPLIER?